TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 NOK)
| Closing information | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) | 
| Turnover | 326,030 | 312,309 | 246,685 | 
| Financial expenses | 4,400 | 84 | 441 | 
| Earnings before taxes | 170,299 | 178,235 | 129,675 | 
| EBITDA | 175,900 | 184,725 | 134,665 | 
| Total assets | 786,373 | 647,555 | 572,462 | 
| Current assets | 483,409 | 337,045 | 276,319 | 
| Current liabilities | 123,292 | 50,028 | 59,135 | 
| Equity capital | 654,748 | 589,839 | 507,107 | 
| - share capital | 651 | 644 | 596 | 
| Employees (average) | 89 | 86 | 75 | 
Financial ratios
| Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) | 
| Solvency | 83.3% | 91.1% | 88.6% | 
| Turnover per employee | 3,663 | 3,632 | 3,289 | 
| Profit as a percentage of turnover | 52.2% | 57.1% | 52.6% | 
| Return on assets (ROA) | 22.2% | 27.5% | 22.7% | 
| Current ratio | 392.1% | 673.7% | 467.3% | 
| Return on equity (ROE) | 26.0% | 30.2% | 25.6% | 
| Change turnover | 10,456 | 45,959 | 13,874 | 
| Change turnover % | 3% | 17% | 6% | 
| Chg. No. of employees | 3 | 11 | 4 | 
| Chg. No. of employees % | 3% | 15% | 6% | 
Total value of public sale
| Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) | 
| Total value of public sale | 0   | 0   | 0 | 
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.
 
         
                    